{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T14:26:15Z","timestamp":1791123975458,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.intimp.2024.112541","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:43:34Z","timestamp":1719276214000},"page":"112541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Repurposing metformin as adjuvant therapy in patients with ulcerative colitis treated with mesalamine: A randomized controlled double-blinded study"],"prefix":"10.1016","volume":"138","author":[{"given":"Sahar M.","family":"El\u2011Haggar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar K.","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha M","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monir M","family":"Bahgat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3332-4573","authenticated-orcid":false,"given":"Mostafa M.","family":"Bahaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.intimp.2024.112541_b0005","first-page":"237","article-title":"Recent advances in the pathogenesis of ulcerative colitis","volume":"31","author":"Xiaohan","year":"2023","journal-title":"Chin. J. Integr. Tradit. West Med. Dig."},{"issue":"2","key":"10.1016\/j.intimp.2024.112541_b0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MCG.0000000000001834","article-title":"Predictors and etiologies of clinical relapse among patients with ulcerative colitis in deep remission","volume":"58","author":"Zeina","year":"2024","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.intimp.2024.112541_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110165","article-title":"Levetiracetam attenuates experimental ulcerative colitis through promoting Nrf2\/HO-1 antioxidant and inhibiting NF-\u03baB, proinflammatory cytokines and iNOS\/NO pathways","volume":"119","author":"Amirshahrokhi","year":"2023","journal-title":"International Immunopharmacology."},{"key":"10.1016\/j.intimp.2024.112541_b0020","doi-asserted-by":"crossref","first-page":"1102420","DOI":"10.3389\/fmed.2022.1102420","article-title":"Disease clearance in ulcerative colitis: Setting the therapeutic goals for future in the treatment of ulcerative colitis","volume":"9","author":"Ramos","year":"2023","journal-title":"Front. Med."},{"issue":"5","key":"10.1016\/j.intimp.2024.112541_b0025","first-page":"469","article-title":"Sphingosine-1-phosphate in inflammatory bowel disease and colitis-associated colon cancer: the fat\u2019s in the fire","volume":"4","author":"Suh","year":"2015","journal-title":"Transl. Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2024.112541_b0030","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/biof.1342","article-title":"Inhibition of the SphK1\/S1P signaling pathway by melatonin in mice with liver fibrosis and human hepatic stellate cells","volume":"43","author":"Gonz\u00e1lez-Fern\u00e1ndez","year":"2017","journal-title":"Biofactors."},{"issue":"12","key":"10.1016\/j.intimp.2024.112541_b0035","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1172\/JCI74188","article-title":"Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs","volume":"124","author":"Degagn\u00e9","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2024.112541_b0040","first-page":"6","article-title":"S1P signaling: new therapies and opportunities","author":"Gonzalez-Cabrera","year":"2014","journal-title":"F1000prime Reports."},{"issue":"2","key":"10.1016\/j.intimp.2024.112541_b0045","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/08923973.2021.1878214","article-title":"Metformin alleviates inflammation in oxazolone induced ulcerative colitis in rats: plausible role of sphingosine kinase 1\/sphingosine 1 phosphate signaling pathway","volume":"43","author":"El-Mahdy","year":"2021","journal-title":"Immunopharmacology and Immunotoxicology."},{"issue":"11","key":"10.1016\/j.intimp.2024.112541_b0050","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.3748\/wjg.v22.i11.3117","article-title":"Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer","volume":"22","author":"Landy","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112541_b0055","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.amjms.2018.11.011","article-title":"Correlation of intestinal mucosal healing and tight junction protein expression in ulcerative colitis patients","volume":"357","author":"Tan","year":"2019","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.intimp.2024.112541_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106368","article-title":"Discoidin domain receptor 1 (DDR1) promote intestinal barrier disruption in Ulcerative Colitis through tight junction proteins degradation and epithelium apoptosis","volume":"183","author":"Li","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.intimp.2024.112541_b0065","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s12010-021-03788-2","article-title":"Caffeic acid phenethyl ester attenuates dextran sulfate sodium-induced ulcerative colitis through modulation of NF-\u03baB and cell adhesion molecules","volume":"194","author":"Pandurangan","year":"2022","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112541_b0070","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00054725-200405000-00001","article-title":"Inflammatory bowel disease is linked to 19p13 and associated with ICAM-1","volume":"10","author":"Low","year":"2004","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.intimp.2024.112541_b0075","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00011-005-1363-8","article-title":"Intercellular adhesion molecule-1 (ICAM-1) in ulcerative colitis: presence, visualization, and significance","volume":"54","author":"Vainer","year":"2005","journal-title":"Inflamm. Res."},{"issue":"3","key":"10.1016\/j.intimp.2024.112541_b0080","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MEG.0000000000002503","article-title":"Impact of metformin on the incidence of human cholangiocarcinoma in diabetic patients: a systematic review and meta-analysis","volume":"35","author":"Laffusa","year":"2023","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.intimp.2024.112541_b0085","doi-asserted-by":"crossref","first-page":"e0135858","DOI":"10.1371\/journal.pone.0135858","article-title":"Metformin ameliorates inflammatory bowel disease by suppression of the STAT3 signaling pathway and regulation of the between Th17\/Treg balance","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS One."},{"issue":"3","key":"10.1016\/j.intimp.2024.112541_b0090","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/jgh.12435","article-title":"Anti-inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis-associated colon cancer","volume":"29","author":"Koh","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112541_b0095","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jclinepi.2011.07.011","article-title":"The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency","volume":"65","author":"Sim","year":"2012","journal-title":"J. Clin. Epidemiol."},{"issue":"12","key":"10.1016\/j.intimp.2024.112541_b0100","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/apt.14688","article-title":"Systematic review: safety of mesalazine in ulcerative colitis","volume":"47","author":"Sehgal","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2024.112541_b0105","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0002-9343(97)00254-4","article-title":"Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial","volume":"103","author":"Garber","year":"1997","journal-title":"Am. J. Med."},{"issue":"12","key":"10.1016\/j.intimp.2024.112541_b0110","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/ibd.20520","article-title":"Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis","volume":"14","author":"Lewis","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"10.1016\/j.intimp.2024.112541_b0115","doi-asserted-by":"crossref","first-page":"e000212","DOI":"10.1136\/bmjgast-2018-000212","article-title":"Golimumab induction and maintenance for moderate to severe ulcerative colitis: results from GO-COLITIS (Golimumab: a Phase 4, UK, open label, single arm study on its utilization and impact in ulcerative Colitis)","volume":"5","author":"Probert","year":"2018","journal-title":"BMJ Open Gastroenterol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112541_b0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrgastro.2009.203","article-title":"Clinical implications of mucosal healing for the management of IBD","volume":"7","author":"Pineton de Chambrun","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112541_b0125","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1179\/108331905X55776","article-title":"Visual analogue scale, numeric pain rating scale and the McGill pain Questionnaire: an overview of psychometric properties","volume":"10","author":"Kahl","year":"2005","journal-title":"Phys. Ther. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2024.112541_b0130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/gutjnl-2015-310187","article-title":"Development and validation of the Nancy histological index for UC","volume":"66","author":"Marchal-Bressenot","year":"2017","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.intimp.2024.112541_b0135","first-page":"150","article-title":"A novel pre-treatment approach to ulcerative colitis in a mouse model","volume":"10","author":"Pouresmaeil","year":"2022","journal-title":"Iranian Journal of Colorectal Research."},{"key":"10.1016\/j.intimp.2024.112541_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107464","article-title":"Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target","volume":"207","author":"Sukocheva","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2024.112541_b0145","first-page":"1","article-title":"Effect of indole-3-carbinol and\/or metformin on female patients with ulcerative colitis (premalignant condition): role of oxidative stress, apoptosis and proinflammatory cytokines","volume":"5","author":"Kabel","year":"2017","journal-title":"J Cancer Res Treat."},{"issue":"5","key":"10.1016\/j.intimp.2024.112541_b0150","first-page":"893","article-title":"The role of mesalamine in the treatment of ulcerative colitis","volume":"3","author":"Karagozian","year":"2007","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.intimp.2024.112541_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109230","article-title":"Repurposing metformin as a potential treatment for inflammatory bowel disease: evidence from cell to the clinic","volume":"112","author":"Wanchaitanawong","year":"2022","journal-title":"International Immunopharmacology."},{"issue":"8","key":"10.1016\/j.intimp.2024.112541_b0160","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1084\/jem.20041948","article-title":"Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator\u2013activated receptor-\u03b3","volume":"201","author":"Rousseaux","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2024.112541_b0165","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.biopha.2017.08.020","article-title":"Metformin maintains mucosal integrity in experimental model of colitis by inhibiting oxidative stress and pro-inflammatory signaling","volume":"94","author":"Pandey","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.intimp.2024.112541_b0170","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/10520295.2020.1776896","article-title":"Metformin alleviates experimental colitis in mice by up-regulating TGF-\u03b2 signaling","volume":"96","author":"Liu","year":"2021","journal-title":"Biotechnic & Histochemistry."},{"issue":"2","key":"10.1016\/j.intimp.2024.112541_b0175","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijcard.2008.04.010","article-title":"Metformin inhibits TNF-\u03b1-induced I\u03baB kinase phosphorylation, I\u03baB-\u03b1 degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation","volume":"134","author":"Huang","year":"2009","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112541_b0180","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4110\/in.2013.13.4.123","article-title":"Metformin down-regulates TNF-\u03b1 secretion via suppression of scavenger receptors in macrophages","volume":"13","author":"Hyun","year":"2013","journal-title":"Immune Network."},{"issue":"2","key":"10.1016\/j.intimp.2024.112541_b0185","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.metabol.2004.08.018","article-title":"Differential regulation of insulin action and tumor necrosis factor \u03b1 system activity by metformin","volume":"54","author":"Biarn\u00e9s","year":"2005","journal-title":"Metabolism"},{"issue":"1\u20133","key":"10.1016\/j.intimp.2024.112541_b0190","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2013.08.040","article-title":"Targeting sphingosine kinase 1 (SphK1) and apoptosis by colon-specific delivery formula of resveratrol in treatment of experimental ulcerative colitis in rats","volume":"718","author":"Abdin","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112541_b0195","doi-asserted-by":"crossref","unstructured":"Xia P, Gamble JR, Rye K-A, Wang L, Hii CS, Cockerill P, et al. Tumor necrosis factor-\u03b1 induces adhesion molecule expression through the sphingosine kinase pathway. Proceedings of the National Academy of Sciences. 1998;95(24):14196-201.","DOI":"10.1073\/pnas.95.24.14196"},{"issue":"5","key":"10.1016\/j.intimp.2024.112541_b0200","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.tice.2015.07.003","article-title":"Effect of metformin and adriamycin on transplantable tumor model","volume":"47","author":"Kabel","year":"2015","journal-title":"Tissue Cell"},{"issue":"4","key":"10.1016\/j.intimp.2024.112541_b0205","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1158\/1541-7786.MCR-18-0409","article-title":"SPHK1 is a novel target of metformin in ovarian cancer","volume":"17","author":"Hart","year":"2019","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2024.112541_b0210","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ccr.2012.11.013","article-title":"Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer","volume":"23","author":"Liang","year":"2013","journal-title":"Cancer Cell."},{"key":"10.1016\/j.intimp.2024.112541_b0215","first-page":"205","article-title":"S1 pping fire: Sphingosine-1-phosphate signaling as an emerging target in inflammatory bowel disease and colitis-associated cancer","author":"Degagn\u00e9","year":"2014","journal-title":"Clin. Exp. Gastroenterol."},{"key":"10.1016\/j.intimp.2024.112541_b0220","article-title":"Phosphorylation of Janus kinase 1 (JAK1) by AMP-activated protein kinase (AMPK) links energy sensing to anti-inflammatory signaling","volume":"9(453):ra109-ra","author":"Rutherford","year":"2016","journal-title":"ScienceSignaling."},{"issue":"6","key":"10.1016\/j.intimp.2024.112541_b0225","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.2337\/db14-1225","article-title":"Metformin inhibits monocyte-to-macrophage differentiation via AMPK-mediated inhibition of STAT3 activation: potential role in atherosclerosis","volume":"64","author":"Vasamsetti","year":"2015","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.intimp.2024.112541_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/etm.2023.12227","article-title":"Metformin regulates the LIN28B-mediated JNK\/STAT3 signaling pathway through miR-140-3p in subretinal fibrosis","volume":"26","author":"Hua","year":"2023","journal-title":"Exp. Ther. Med."},{"issue":"3","key":"10.1016\/j.intimp.2024.112541_b0235","doi-asserted-by":"crossref","first-page":"e0193031","DOI":"10.1371\/journal.pone.0193031","article-title":"Metformin suppresses retinal angiogenesis and inflammation in vitro and in vivo","volume":"13","author":"Han","year":"2018","journal-title":"PLoS One."},{"issue":"3","key":"10.1016\/j.intimp.2024.112541_b0240","first-page":"1817","article-title":"Protective effects of metformin on lipopolysaccharide-induced airway epithelial cell injury via NF-\u03baB signaling inhibition","volume":"19","author":"Sun","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2024.112541_b0245","first-page":"80","article-title":"Sphingosine 1-phosphate-induced ICAM-1 expression via NADPH oxidase\/ROS-dependent NF-\u03baB cascade on human pulmonary alveolar epithelial cells","volume":"7","author":"Lin","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112541_b0250","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/jcmm.13342","article-title":"Metformin protects against intestinal barrier dysfunction via AMPK\u03b11-dependent inhibition of JNK signalling activation","volume":"22","author":"Deng","year":"2018","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.112541_b0255","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jss.2006.07.050","article-title":"Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis","volume":"140","author":"Poritz","year":"2007","journal-title":"J. Surg. Res."},{"issue":"6","key":"10.1016\/j.intimp.2024.112541_b0260","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.ajpath.2013.09.001","article-title":"TNF-\u03b1 modulation of intestinal epithelial tight junction barrier is regulated by ERK1\/2 activation of Elk-1","volume":"183","author":"Al-Sadi","year":"2013","journal-title":"The American Journal of Pathology."},{"issue":"3","key":"10.1016\/j.intimp.2024.112541_b0265","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bbrc.2015.03.125","article-title":"1, 25-Dihydroxyvitamin D3 preserves intestinal epithelial barrier function from TNF-\u03b1 induced injury via suppression of NF-kB p65 mediated MLCK-P-MLC signaling pathway","volume":"460","author":"Chen","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"22","key":"10.1016\/j.intimp.2024.112541_b0270","article-title":"Metformin regulates tight junction of intestinal epithelial cells via MLCK-MLC signaling pathway","volume":"21","author":"Zhou","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2024.112541_b0275","doi-asserted-by":"crossref","unstructured":"Caviglia GP, Dughera F, Ribaldone DG, Rosso C, Abate ML, Pellicano R, et al. Serum zonulin in patients with inflammatory bowel disease: A pilot study. 2019.","DOI":"10.23736\/S0026-4806.18.05787-7"},{"key":"10.1016\/j.intimp.2024.112541_b0280","first-page":"9","article-title":"All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases","author":"Fasano","year":"2020","journal-title":"F1000Research"},{"issue":"4","key":"10.1016\/j.intimp.2024.112541_b0285","doi-asserted-by":"crossref","first-page":"e1251384","DOI":"10.1080\/21688370.2016.1251384","article-title":"Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases","volume":"4","author":"Sturgeon","year":"2016","journal-title":"Tissue Barriers."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924010622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924010622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T17:22:38Z","timestamp":1722360158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924010622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":57,"alternative-id":["S1567576924010622"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112541","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing metformin as adjuvant therapy in patients with ulcerative colitis treated with mesalamine: A randomized controlled double-blinded study","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112541","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112541"}}